Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's Spielberg Wants NIH/FDA Collaborations To Focus On Problem-Solving

This article was originally published in The Pink Sheet Daily

Executive Summary

NIH research could help FDA overcome pressing scientific hurdles and provide a rational basis for regulatory decision-making, the agency's new deputy commissioner for medical products and tobacco tells the Alliance for a Stronger FDA.
Advertisement

Related Content

Learning To Drive The ‘Chariot’: FDA Deputy Califf’s New Role
Will NCATS Become More Than The Sum Of Its Parts?
FDA's Spielberg To Focus On Cross-Center Collaboration, Hamburg Says
FDA Reorganization Creates Prominent Roles For Mercy Hospital's Spielberg, CDER's Autor
FDA Reorganization Creates Prominent Roles For Mercy Hospital's Spielberg, CDER's Autor

Topics

Advertisement
UsernamePublicRestriction

Register

PS072946

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel